<DOC>
	<DOCNO>NCT02772315</DOCNO>
	<brief_summary>The purpose study assess validity usefulness omics signature improve identification risk stratification patient endocrine hypertension stratification patient primary hypertension .</brief_summary>
	<brief_title>Omics Signature Diagnosis Hypertension</brief_title>
	<detailed_description>Arterial hypertension important cause death world . At referral hypertension center 25 % patient single cause hypertension , so-called secondary hypertension , mostly endocrine , adrenal origin ( primary aldosteronism , pheochromocytoma/ paraganglioma , Cushing 's syndrome ) . This rate step 50 % patient drug resistant hypertension . Proper treatment secondary hypertension improve prognosis considerably depend adequate diagnosis . Classically diagnosis form hypertension rest cumbersome biochemical imaging procedure may completely take away uncertainty . Modern '-omics ' technique ( genomics , metabolomics , proteomics plasma urine ) may allow fast good diagnosis . In addition , may provide basis stratification hypertensive patient identifiable cause hypertension , so-called primary hypertension . This stratification may help predict response antihypertensive drug determine prognosis thus , help establish personalized medicine hypertension care .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Aged 18 75 year old A sign date informed consent form A diagnosis hypertension define either : Use antihypertensive drug ( ) Arterial hypertension : untreated patient must confirm daytime ambulatory blood pressure monitoring ( ABPM ) , home blood pressure monitoring , blood pressure high equal 135 mmHg systolic blood pressure and/or high equal 85 mmHg diastolic blood pressure . In order eligible participate nest case control study , subject must also meet follow criterion : A conformed diagnosis PA , PPGL CS case patient PHT ( exclusion secondary form ) match counterpart Any severe comorbid condition , accord attend physician , could decrease life expectancy le 3 year Any active malignancy unrelated adrenal disease PPGL Guardianship incapacity A potential control subject meet follow criterion exclude participation nest case control study case : Existence form secondary hypertension renal artery stenosis , renal disease , Munchausen 's syndrome patient induces hypertension regardless method . Druginduced ( include factitious use illicit substance ) hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>genomics</keyword>
	<keyword>proteomics</keyword>
	<keyword>metabolomics</keyword>
	<keyword>endocrine hypertension</keyword>
	<keyword>primary aldosteronism</keyword>
	<keyword>Cushing syndrom</keyword>
	<keyword>pheochromocytoma</keyword>
</DOC>